Effects of dose and age on adverse events associated with tadalafil in the treatment of pulmonary arterial hypertension

Por Berman-Rosenzweig, Erika, Arneson, Carl, Klinger, James R.
Publicado em 2014

Two Cases of Pulmonary Hypertension Associated with Type III Glycogen Storage Disease

Por Lee, Teresa M., Berman-Rosenzweig, Erika S., Slonim, Alfred E., Chung, Wendy K.
Publicado em 2011

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs

Por Grunig, Gabriele, Baghdassarian, Aram, Park, Sung-Hyun, Pylawka, Serhiy, Bleck, Bertram, Reibman, Joan, Berman-Rosenzweig, Erika, Durmus, Nedim
Publicado no Biomark Insights (2016)

Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom

Por Gladwin, Mark T., Barst, Robyn J., Gibbs, J. Simon R., Hildesheim, Mariana, Sachdev, Vandana, Nouraie, Mehdi, Hassell, Kathryn L., Little, Jane A., Schraufnagel, Dean E., Krishnamurti, Lakshmanan, Novelli, Enrico, Girgis, Reda E., Morris, Claudia R., Berman Rosenzweig, Erika, Badesch, David B., Lanzkron, Sophie, Castro, Oswaldo L., Taylor, James G., Goldsmith, Jonathan C., Kato, Gregory J., Gordeuk, Victor R., Machado, Roberto F.
Publicado em 2014